DOCSLIB.ORG

Identification of Candidate Lung Cancer Susceptibility Genes in Mouse Using Oligonucleotide Arrays W J Lemon*, H Bernert*, H Sun, Y Wang, M You

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Identification of Candidate Lung Cancer Susceptibility Genes in Mouse Using Oligonucleotide Arrays W J Lemon*, H Bernert*, H Sun, Y Wang, M You 644 ORIGINAL ARTICLE J Med Genet: first published as 10.1136/jmg.39.9.644 on 1 September 2002. Downloaded from Identification of candidate lung cancer susceptibility genes in mouse using oligonucleotide arrays W J Lemon*, H Bernert*, H Sun, Y Wang, M You ............................................................................................................................. See end of article for J Med Genet 2002;39:644–655 authors’ affiliations *These two authors contributed equally to this work. ....................... We applied microarray gene expression profiling to lungs from mouse strains having variable suscep- Correspondence to: Dr M You, Manuel tibility to lung tumour development as a means to identify, within known quantitative trait loci (QTLs), Tzagournis Medical candidate genes responsible for susceptibility or resistance to lung cancer. At least eight chromosomal Research Facility, Room regions of mice have been mapped and verified to be linked with lung tumour susceptibility or resist- 530, 420W West 12th ance. In this study, high density oligonucleotide arrays were used to measure the relative expression Avenue, Columbus, Ohio levels of >36 000 genes and ESTs in lung tissues of A/J, BALB/cJ, SM/J, C3H/HeJ, and C57BL/6J 43210, USA; [email protected] mice. A number of differentially expressed genes were found in each of the lung cancer susceptibility QTLs. Bioinformatic analysis of the differentially expressed genes located within QTLs produced 28 Revised version received susceptibility candidates and 22 resistance candidates. These candidates may be extremely helpful in 31 May 2002 Accepted for publication the ultimate identification of the precise genes responsible for lung tumour susceptibility or resistance in 14 June 2002 mice and, through follow up, humans. Complete data sets are available at http://thinker.med.ohio- ....................... state.edu. umerous chromosomal regions genetically linked with homologous to human chromosome 6p21; potential candi- susceptibility or resistance to pulmonary adenomas dates at this location are the genes for tumour necrosis factor Nhave been described in mice using inbred strains α and β. Similarly, linkages to lung tumour susceptibility were showing widely different susceptibilities to formation of both also seen at markers on chromosome 19 (Pas3), accounting for spontaneous and chemical induced lung tumours.1–3 Suscepti- 3% of the phenotypic variation in a study on (A/J × C57BL/6J) bility is intrinsic to the lung itself as shown by the classical × C57BL/6J mice, and 2% of the explained phenotypic × experiments involving lung explants from sensitive and variation when (A/J C57BL/6J) F2 mice were used. In this 45 resistant mice. After carcinogen administration to F1 mice latter study, suggestive linkage to a locus on chromosome 9 previously made host to these explants, only the lungs from (Pas4) was determined to explain 4% of the total phenotypic the sensitive mouse strain developed tumours.45 Matings of variance.89Mouse-human synteny for all loci can be examined http://jmg.bmj.com/ sensitive A/J and resistant C57BL/6J mice produce F1 and F2 in detail using the Homology browser at the NCBI offspring, which are of intermediate sensitivity to tumour (www.ncbi.nlm.nih.gov/Homology). induction, thus implicating more than one gene and illustrat- At present, four Par QTLs have been mapped using F2 or ing that tumour size and number are multigenic quantitative backcross populations of mice, including Parl (chromosome traits.6 Production of recombinant inbred (RI) lines of A/J (A) 11), Par2 (chromosome 18), Par3 (chromosome 12), and Par4 and C57BL/6J (B6) mice and subsequent analysis of their (chromosome 4).12 Par1 is a lung tumour resistance locus that tumour sensitivities suggested that three genes, one major was mapped in (A/J × M spretus) × C57BL/6J mice to the and two minor genes, were involved in determining the sensi- retinoic acid receptor-α (Rara) gene locus on chromosome on October 2, 2021 by guest. Protected copyright. tivity to mouse lung tumour development.6 Subsequent 11.13 14 Contributed by the M spretus allele, Par1 gave a linkage studies have identified pulmonary adenoma suscepti- maximum lod score of 5.3 accounting for 23% of phenotypic bility (Pas) and pulmonary adenoma resistance (Par) loci. We variance when coexpressed with the highly penetrant Pas1 thus adopt the definition of quantitative trait locus (QTL) as a allele of the A/J strain. In mice carrying the M spretus instead known chromosomal region in which one or more genes are of the A/J allele of the Pas1 gene, the resistant effect of Par1 on likely to underlie the linkage. tumour incidence, multiplicity, and volume was lessened by Listed in table 1 are the selected QTLs that have been about a half. Par1 behaves like a modulator of Pas1, to some mapped in various mouse crosses. A major susceptibility locus degree subduing the dominant effect of Pas1 on lung tumori- × × was mapped in (A/J C3H/HeJ) F2 mice to distal chromosome genesis. Par2 was mapped by linkage studies on (A/J BALB/ × × 6 and was termed the Pas1 locus. This locus produced a maxi- cByJ) A/J and (A/JO1aHsd BALB/cO1aHsd) F2 mice to mum logarithm of the likelihood ratio (lod) score of 9 and chromosome 18 at microsatellite marker D18MIT103. A lod accounted for approximately 45% of the observed phenotypic score of 12.2 was reported at this locus, with a phenotypic variance.7 A lod score of 3 or greater is considered significant variance of 38% for resistance to tumour induction.15 This for linkage. Consistent results were obtained in comprehen- locus was termed Par2. In our own analysis of (A/JO1aHsd × × sive linkage studies using (A/J C57BL/6J) F2 (60% of BALB/cO1aHsd) F2 mice, Par2 had a significant linkage to lung variance), (A/J × C57BL/6J) × C57BL/6J (16% of variance), tumour resistance and produced a maximum lod score of (A/J × M spretus) × C57BL/6J (34% of variance), and A × B & B 11.16 The greatest linkage occurred at the site of the Dcc tumour × A RI mice (51% of variance).8–11 Three other loci were repressor gene.16 Par3 was mapped to chromosome 12 with a mapped to chromosomes 17, 19, and 9.89Linkage to a locus on lod score of 6.47, using backcross population between chromosome 17, the site of the putative Pas2 locus, was SMXA24 RI mice and A/J mice.14 Par3 seems to have a stronger × observed in (A/J C57BL/6J) F2, accounting for 8% of the total resistance to lung tumour induction when coexpressed with variance in phenotype. The location of the Pas2 locus is the A/J allele of the Par2.17 Finally, Par4 or Papg1 was mapped www.jmedgenet.com Mouse lung cancer susceptibility candidates Table 1 Summary of Pas and Par QTLs. Pas QTLs have been largely studied using various genetic crosses of A/J and C57BL/6J; Par 1 and 3 using A/J and SM/J; Par 2 and 4 using A/J and BALB/cJ. Markers flanking the QTLs were taken larger than what some recent fine mapping studies have produced in order to allow identification of multiple genes Start marker End marker Explained Locus Strains Breeding variance Name Genetic Celera Name Genetic Celera Celera Transcripts Affymetrix Mu74K Pas 1 A × B6 F2 60% D6Mit54 48.2 109, 249, 790 D6Mit304 75 142, 276, 365 640 250 Pas 2 A × B6 B6 × A RI 8 D17Mit23 17 22, 057, 276 D17Mit50 23.2 39, 136, 371 468 119 Pas 3 A × B6 F2 2 D19Mit42 2 6, 828, 495 D19Mit19 25 39, 976, 948 295 61 Pas 4 A × B6 F2 4 D9Mit11 42 82, 499, 293 D9Mit282 72 114, 926, 441 932 213 Par 1 (SMXA × A) × ABC ∼10 D11Mit4 37 69, 772, 571 D11Mit14 59 101, 055, 855 1043 345 Par 2 A × B/c F2 ∼50 D18Mit124 32 57, 893, 422 D18Mit4 57 83, 071, 801 373 92 Par 3 (SMXA × A) × ABC ∼10 D12Mit36 13 52, 195, 168 D12Mit6 44 81, 478, 562 457 79 Par 4 A × B/c F2 ∼10 D4Mit39 10.6 32, 493, 011 D4Mit77 42.5 83, 848, 148 611 111 nucleotide arrayent (Santa aliquots were Clara, hybridised to CA): each Affymetrix Mu74Av2 mouse oligo- (A array), from 30 microarray). Singletonturers’ cRNA preparations protocolsour were microarray (www.cancergenetics.med.ohio-state.edu/ produced core facilityRNA samples according were further to purified, standard labelled,Microarray and manufac- analysis processed by mined by reading absorbance atmaldehyde 260/280 nm. agarose gel,Rnase free and water. The the qualitythe of RNA concentration RNA was pellet confirmed was was on30 washed minutes. deter- a After in for- centrifugation at 75% 14 ethanolwith 000 an rpm and equal for dissolved 15 volume minutes, of in minutes; isopropanol, and the incubated on aqueous ice phase for minutes. was The transferred sample tochloroform, was a centrifuged vigorous fresh at mixing, tube 14 and 000 incubation rpm on for ice 20 for 15 mouse strains. for lung cancer susceptibilityregions or resistance for in the several identificationdifferential relevant gene of expression candidate in genes lungwe cancer responsible susceptibility used QTL microarray profiling high to identify densityCelera mouse candidate genome genes. sequence oligonucleotide Specifically, and lungsignificant cancer challenge. genetics arrays with In thepolymorphism to present study, of we detect such combinedEvaluation the a of large differentialresponsible, number fine gene mapping of may expression provefew genes to genes and be can more separated be nucleotide challenging.most by of a more the effect thantypically attributed a assume to that few one the or QTL. centimorgans verybe If few are localised genes several are to genes responsible a or for ficult. 20-30 a One cM obstacle QTL is region. thefor fact Fine the that mapping lung several cancer studies hundred susceptibility genes QTLs can proves to be rather dif- minutes at room temperature,then followed by homogenised addition in of 1nati, 200 ml OH).
Load more

Recommended publications
  • Viewed the Thesis/Dissertation in Its Final Electronic Format and Certify That It Is an Accurate Copy of the Document Reviewed and Approved by the Committee
    U UNIVERSITY OF CINCINNATI Date: I, , hereby submit this original work as part of the requirements for the degree of: in It is entitled: Student Signature: This work and its defense approved by: Committee Chair: Approval of the electronic document: I have reviewed the Thesis/Dissertation in its final electronic format and certify that it is an accurate copy of the document reviewed and approved by the committee. Committee Chair signature: Investigation of Phosphorylated Proteins and Peptides in Human Cerebrospinal Fluid via High-Performance Liquid Chromatography Coupled to Elemental and Molecular Mass Spectrometry A thesis submitted to the Graduate School of the University of Cincinnati In partial fulfillment of the Requirements for the degree of MASTER OF SCIENCE In the Department of Chemistry of the College of Arts and Sciences By ORVILLE DEAN STUART B.S., Chemistry The University of Texas at Tyler, Tyler, Texas May 2006 Committee Chair: Joseph A. Caruso, Ph.D Abstract Cerebrospinal fluid (CSF) surrounds and serves as a protective media for the brain and central nervous system (CNS). This fluid remains isolated from other biological matrices in normal bodily conditions, therefore, an in depth analysis of CSF has the potential to reveal important details and malfunctions of many diseases that plague the nervous system. Because phosphorylation of a wide variety of proteins governs the activity of biological enzymes and systems, a method for the detection of 31P in proteins found in human cerebrospinal fluid by high-performance liquid chromatography (HPLC) coupled to inductively coupled plasma mass spectrometry (ICPMS) is described. Specifically, it is of interest to compare phosphorylated proteins/peptides from patients suffering from post subarachnoid hemorrhage (SAH) arterial vasospasms against CSF from non-diseased patients.
    [Show full text]
  • The Porcine Major Histocompatibility Complex and Related Paralogous Regions: a Review Patrick Chardon, Christine Renard, Claire Gaillard, Marcel Vaiman
    The porcine Major Histocompatibility Complex and related paralogous regions: a review Patrick Chardon, Christine Renard, Claire Gaillard, Marcel Vaiman To cite this version: Patrick Chardon, Christine Renard, Claire Gaillard, Marcel Vaiman. The porcine Major Histocom- patibility Complex and related paralogous regions: a review. Genetics Selection Evolution, BioMed Central, 2000, 32 (2), pp.109-128. 10.1051/gse:2000101. hal-00894302 HAL Id: hal-00894302 https://hal.archives-ouvertes.fr/hal-00894302 Submitted on 1 Jan 2000 HAL is a multi-disciplinary open access L’archive ouverte pluridisciplinaire HAL, est archive for the deposit and dissemination of sci- destinée au dépôt et à la diffusion de documents entific research documents, whether they are pub- scientifiques de niveau recherche, publiés ou non, lished or not. The documents may come from émanant des établissements d’enseignement et de teaching and research institutions in France or recherche français ou étrangers, des laboratoires abroad, or from public or private research centers. publics ou privés. Genet. Sel. Evol. 32 (2000) 109–128 109 c INRA, EDP Sciences Review The porcine Major Histocompatibility Complex and related paralogous regions: a review Patrick CHARDON, Christine RENARD, Claire ROGEL GAILLARD, Marcel VAIMAN Laboratoire de radiobiologie et d’etude du genome, Departement de genetique animale, Institut national de la recherche agronomique, Commissariat al’energie atomique, 78352, Jouy-en-Josas Cedex, France (Received 18 November 1999; accepted 17 January 2000) Abstract – The physical alignment of the entire region of the pig major histocompat- ibility complex (MHC) has been almost completed. In swine, the MHC is called the SLA (swine leukocyte antigen) and most of its class I region has been sequenced.
    [Show full text]
  • Genome-Wide Gene and Pathway Analysis
    European Journal of Human Genetics (2010) 18, 1045–1053 & 2010 Macmillan Publishers Limited All rights reserved 1018-4813/10 www.nature.com/ejhg ARTICLE Genome-wide gene and pathway analysis Li Luo1, Gang Peng1, Yun Zhu2, Hua Dong1,2, Christopher I Amos3 and Momiao Xiong*,1 Current GWAS have primarily focused on testing association of single SNPs. To only test for association of single SNPs has limited utility and is insufficient to dissect the complex genetic structure of many common diseases. To meet conceptual and technical challenges raised by GWAS, we suggest gene and pathway-based GWAS as complementary to the current single SNP-based GWAS. This publication develops three statistics for testing association of genes and pathways with disease: linear combination test, quadratic test and decorrelation test, which take correlations among SNPs within a gene or genes within a pathway into account. The null distribution of the suggested statistics is examined and the statistics are applied to GWAS of rheumatoid arthritis in the Wellcome Trust Case–Control Consortium and the North American Rheumatoid Arthritis Consortium studies. The preliminary results show that the suggested gene and pathway-based GWAS offer several remarkable features. First, not only can they identify the genes that have large genetic effects, but also they can detect new genes in which each single SNP conferred a small amount of disease risk, and their joint actions can be implicated in the development of diseases. Second, gene and pathway-based analysis can allow the formation of the core of pathway definition of complex diseases and unravel the functional bases of an association finding.
    [Show full text]
  • Splicing Alternativo Y Quimerismo En Genes Del MHC De Clase III
    UNIVERSIDAD AUTÓNOMA DE MADRID FACULTAD DE CIENCIAS DEPARTAMENTO DE BIOLOGÍA Splicing alternativo y quimerismo en genes del MHC de clase III. Relación de esta región con la Artritis Reumatoide. Alternative splicing and chimerism in MHC class III genes. Relation of this region to Rheumatoid Arthritis. Memoria presentada por: Raquel López Díez para optar al grado de Doctor en Ciencias por la Universidad Autónoma de Madrid Trabajo dirigido por la Dra Begoña Aguado Orea y realizado en el Centro de Biología Molecular “Severo Ochoa” (UAM-CSIC). Madrid, 2014 DEPARTAMENTO DE BIOLOGÍA FACULTAD DE CIENCIAS UNIVERSIDAD AUTÓNOMA DE MADRID Memoria presentada por Dña Raquel López Díez para optar al grado de Doctor por la Universidad Autónoma de Madrid Directora: Dra. Begoña Aguado Orea Tutor: Dr. José Miguel Hermoso Núñez Departamento de Biología, Centro de Biología Molecular Severo Ochoa, U.A.M.-C.S.I.C. Madrid, 2014 Este trabajo ha sido realizado en el Departamento de Biología de la Facultad de Ciencias y en el Centro de Biología Molecular Severo Ochoa (C.B.M.S.O.), U.A.M.-C.S.I.C., gracias a la ayuda de una beca de Formación para Personal Universitario de la Universidad Autónoma de Madrid. ÍNDICE Abreviaturas empleadas ________________________________________________ vi SUMMARY ___________________________________________________________ ix Publications __________________________________________________________ xv Communications to meetings ____________________________________________ xv Submissions to the NCBI database ________________________________________ xv 1. INTRODUCCIÓN ___________________________________________________ 1 1.1. EL FENÓMENO DEL SPLICING Y EL SPLICING ALTERNATIVO ______________________ 3 1.1.1. Mecanismo de splicing _______________________________________________________ 4 1.1.1.1. Excepciones en el mecanismo de splicing _____________________________________ 8 1.1.2.
    [Show full text]
  • WO 2012/174282 A2 20 December 2012 (20.12.2012) P O P C T
    (12) INTERNATIONAL APPLICATION PUBLISHED UNDER THE PATENT COOPERATION TREATY (PCT) (19) World Intellectual Property Organization International Bureau (10) International Publication Number (43) International Publication Date WO 2012/174282 A2 20 December 2012 (20.12.2012) P O P C T (51) International Patent Classification: David [US/US]; 13539 N . 95th Way, Scottsdale, AZ C12Q 1/68 (2006.01) 85260 (US). (21) International Application Number: (74) Agent: AKHAVAN, Ramin; Caris Science, Inc., 6655 N . PCT/US20 12/0425 19 Macarthur Blvd., Irving, TX 75039 (US). (22) International Filing Date: (81) Designated States (unless otherwise indicated, for every 14 June 2012 (14.06.2012) kind of national protection available): AE, AG, AL, AM, AO, AT, AU, AZ, BA, BB, BG, BH, BR, BW, BY, BZ, English (25) Filing Language: CA, CH, CL, CN, CO, CR, CU, CZ, DE, DK, DM, DO, Publication Language: English DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, GT, HN, HR, HU, ID, IL, IN, IS, JP, KE, KG, KM, KN, KP, KR, (30) Priority Data: KZ, LA, LC, LK, LR, LS, LT, LU, LY, MA, MD, ME, 61/497,895 16 June 201 1 (16.06.201 1) US MG, MK, MN, MW, MX, MY, MZ, NA, NG, NI, NO, NZ, 61/499,138 20 June 201 1 (20.06.201 1) US OM, PE, PG, PH, PL, PT, QA, RO, RS, RU, RW, SC, SD, 61/501,680 27 June 201 1 (27.06.201 1) u s SE, SG, SK, SL, SM, ST, SV, SY, TH, TJ, TM, TN, TR, 61/506,019 8 July 201 1(08.07.201 1) u s TT, TZ, UA, UG, US, UZ, VC, VN, ZA, ZM, ZW.
    [Show full text]
  • Family a and B DNA Polymerases in Cancer: Opportunities for Therapeutic Interventions
    biology Review Family A and B DNA Polymerases in Cancer: Opportunities for Therapeutic Interventions Vinit Shanbhag 1,2, Shrikesh Sachdev 2,3, Jacqueline A. Flores 2,3, Mukund J. Modak 4 and Kamalendra Singh 2,3,4,5,* 1 Department of Biochemistry, University of Missouri, Columbia, MO 65211, USA; [email protected] 2 The Christopher S. Bond Life Science Center, University of Missouri, Columbia, MO 65211, USA; [email protected] (S.S.); [email protected] (J.A.F.) 3 Molecular Microbiology and Immunology, University of Missouri, Columbia, MO 65211, USA 4 Department of Microbiology, Biochemistry and Molecular Genetics 225 Warren Street, NJ 07103, USA; [email protected] 5 Department of Laboratory Medicine, Karolinska Institutet, Stockholm 141 86, Sweden * Correspondence: [email protected]; Tel.: +1-573-882-9024 Received: 13 November 2017; Accepted: 29 December 2017; Published: 2 January 2018 Abstract: DNA polymerases are essential for genome replication, DNA repair and translesion DNA synthesis (TLS). Broadly, these enzymes belong to two groups: replicative and non-replicative DNA polymerases. A considerable body of data suggests that both groups of DNA polymerases are associated with cancer. Many mutations in cancer cells are either the result of error-prone DNA synthesis by non-replicative polymerases, or the inability of replicative DNA polymerases to proofread mismatched nucleotides due to mutations in 30-50 exonuclease activity. Moreover, non-replicative, TLS-capable DNA polymerases can negatively impact cancer treatment by synthesizing DNA past lesions generated from treatments such as cisplatin, oxaliplatin, etoposide, bleomycin, and radiotherapy. Hence, the inhibition of DNA polymerases in tumor cells has the potential to enhance treatment outcomes.
    [Show full text]
  • A Free-Living Protist That Lacks Canonical Eukaryotic DNA Replication and Segregation Systems
    bioRxiv preprint doi: https://doi.org/10.1101/2021.03.14.435266; this version posted March 15, 2021. The copyright holder for this preprint (which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under aCC-BY-NC-ND 4.0 International license. 1 A free-living protist that lacks canonical eukaryotic DNA replication and segregation systems 2 Dayana E. Salas-Leiva1, Eelco C. Tromer2,3, Bruce A. Curtis1, Jon Jerlström-Hultqvist1, Martin 3 Kolisko4, Zhenzhen Yi5, Joan S. Salas-Leiva6, Lucie Gallot-Lavallée1, Geert J. P. L. Kops3, John M. 4 Archibald1, Alastair G. B. Simpson7 and Andrew J. Roger1* 5 1Centre for Comparative Genomics and Evolutionary Bioinformatics (CGEB), Department of 6 Biochemistry and Molecular Biology, Dalhousie University, Halifax, NS, Canada, B3H 4R2 2 7 Department of Biochemistry, University of Cambridge, Cambridge, United Kingdom 8 3Oncode Institute, Hubrecht Institute – KNAW (Royal Netherlands Academy of Arts and Sciences) 9 and University Medical Centre Utrecht, Utrecht, The Netherlands 10 4Institute of Parasitology Biology Centre, Czech Acad. Sci, České Budějovice, Czech Republic 11 5Guangzhou Key Laboratory of Subtropical Biodiversity and Biomonitoring, School of Life Science, 12 South China Normal University, Guangzhou 510631, China 13 6CONACyT-Centro de Investigación en Materiales Avanzados, Departamento de medio ambiente y 14 energía, Miguel de Cervantes 120, Complejo Industrial Chihuahua, 31136 Chihuahua, Chih., México 15 7Centre for Comparative Genomics and Evolutionary Bioinformatics (CGEB), Department of 16 Biology, Dalhousie University, Halifax, NS, Canada, B3H 4R2 17 *corresponding author: [email protected] 18 D.E.S-L ORCID iD: 0000-0003-2356-3351 19 E.C.T.
    [Show full text]
  • DNA Polymerases at the Eukaryotic Replication Fork Thirty Years After: Connection to Cancer
    cancers Review DNA Polymerases at the Eukaryotic Replication Fork Thirty Years after: Connection to Cancer Youri I. Pavlov 1,2,* , Anna S. Zhuk 3 and Elena I. Stepchenkova 2,4 1 Eppley Institute for Research in Cancer and Allied Diseases and Buffett Cancer Center, University of Nebraska Medical Center, Omaha, NE 68198, USA 2 Department of Genetics and Biotechnology, Saint-Petersburg State University, 199034 Saint Petersburg, Russia; [email protected] 3 International Laboratory of Computer Technologies, ITMO University, 197101 Saint Petersburg, Russia; [email protected] 4 Laboratory of Mutagenesis and Genetic Toxicology, Vavilov Institute of General Genetics, Saint-Petersburg Branch, Russian Academy of Sciences, 199034 Saint Petersburg, Russia * Correspondence: [email protected] Received: 30 September 2020; Accepted: 13 November 2020; Published: 24 November 2020 Simple Summary: The etiology of cancer is linked to the occurrence of mutations during the reduplication of genetic material. Mutations leading to low replication fidelity are the culprits of many hereditary and sporadic cancers. The archetype of the current model of replication fork was proposed 30 years ago. In the sequel to our 2010 review with the words “years after” in the title inspired by A. Dumas’s novels, we go over new developments in the DNA replication field and analyze how they help elucidate the effects of the genetic variants of DNA polymerases on cancer. Abstract: Recent studies on tumor genomes revealed that mutations in genes of replicative DNA polymerases cause a predisposition for cancer by increasing genome instability. The past 10 years have uncovered exciting details about the structure and function of replicative DNA polymerases and the replication fork organization.
    [Show full text]
  • Genes Between the Complement Cluster and HLA-B THOMAS SPIES*, MAUREEN BRESNAHAN, and JACK L
    Proc. Nati. Acad. Sci. USA Vol. 86, pp. 8955-8958, November 1989 Immunology Human major histocompatibility complex contains a minimum of 19 genes between the complement cluster and HLA-B THOMAS SPIES*, MAUREEN BRESNAHAN, AND JACK L. STROMINGER Department of Biochemistry and Molecular Biology, Harvard University, Cambridge, MA 02138 Contributed by Jack L. Strominger, August 15, 1989 ABSTRACT A 600-kilobase (kb) DNA segment from the meric side, the gene for 21-OHB is 350 kb distant from the human major histocompatibility complex (MHC) class HI nearest class II locus, DR. Presently, no genes have been region was isolated by extension of a previous 435-kb chromo- localized within this region. On the telomeric side, the gene some walk. The contiguous series of cloned overlapping for C2 is separated by 600 kb from the proximal class I locus, cosmids contains the entire 555-kb interval between C2 in the HLA-B. This interval includes the genes for the tumor complement gene cluster and HLA-B. This region is known to necrosis factors (TNFs) a and 83 and the major heat shock encode the tumor necrosis factors (TNFs) a and (, B144, and protein HSP70 (7, 8, 11). the major heat shock protein HSP70. Moreover, a cluster of To identify genes within the MHC class III region, a 435-kb genes, BAT1-BAT5 (HLA-B-associated transcripts) has been genomic segment centromeric to HLA-B has recently been localized in the vicinity of the genes for TNFa and TNF3. An isolated by chromosome walking with overlapping cosmids additional four genes were identified by isolation of corre- (12).
    [Show full text]
  • Analysis of Protein Dynamics at Active, Stalled, and Collapsed Replication Forks
    Downloaded from genesdev.cshlp.org on October 4, 2021 - Published by Cold Spring Harbor Laboratory Press Analysis of protein dynamics at active, stalled, and collapsed replication forks Bianca M. Sirbu, Frank B. Couch, Jordan T. Feigerle, Srividya Bhaskara, Scott W. Hiebert, and David Cortez1 Department of Biochemistry, Vanderbilt University School of Medicine, Nashville, Tennessee 37232, USA Successful DNA replication and packaging of newly synthesized DNA into chromatin are essential to maintain genome integrity. Defects in the DNA template challenge genetic and epigenetic inheritance. Unfortunately, tracking DNA damage responses (DDRs), histone deposition, and chromatin maturation at replication forks is difficult in mammalian cells. Here we describe a technology called iPOND (isolation of proteins on nascent DNA) to analyze proteins at active and damaged replication forks at high resolution. Using this methodology, we define the timing of histone deposition and chromatin maturation. Class 1 histone deacetylases are enriched at replisomes and remove predeposition marks on histone H4. Chromatin maturation continues even when decoupled from replisome movement. Furthermore, fork stalling causes changes in the recruitment and phosphorylation of proteins at the damaged fork. Checkpoint kinases catalyze H2AX phosphorylation, which spreads from the stalled fork to include a large chromatin domain even prior to fork collapse and double-strand break formation. Finally, we demonstrate a switch in the DDR at persistently stalled forks that includes MRE11-dependent RAD51 assembly. These data reveal a dynamic recruitment of proteins and post-translational modifications at damaged forks and surrounding chromatin. Furthermore, our studies establish iPOND as a useful methodology to study DNA replication and chromatin maturation. [Keywords: DNA replication; chromatin; DNA damage response; H2AX; histone acetylation; EdU; click chemistry] Supplemental material is available for this article.
    [Show full text]
  • The Genetic Program of Pancreatic Beta-Cell Replication in Vivo
    Page 1 of 65 Diabetes The genetic program of pancreatic beta-cell replication in vivo Agnes Klochendler1, Inbal Caspi2, Noa Corem1, Maya Moran3, Oriel Friedlich1, Sharona Elgavish4, Yuval Nevo4, Aharon Helman1, Benjamin Glaser5, Amir Eden3, Shalev Itzkovitz2, Yuval Dor1,* 1Department of Developmental Biology and Cancer Research, The Institute for Medical Research Israel-Canada, The Hebrew University-Hadassah Medical School, Jerusalem 91120, Israel 2Department of Molecular Cell Biology, Weizmann Institute of Science, Rehovot, Israel. 3Department of Cell and Developmental Biology, The Silberman Institute of Life Sciences, The Hebrew University of Jerusalem, Jerusalem 91904, Israel 4Info-CORE, Bioinformatics Unit of the I-CORE Computation Center, The Hebrew University and Hadassah, The Institute for Medical Research Israel- Canada, The Hebrew University-Hadassah Medical School, Jerusalem 91120, Israel 5Endocrinology and Metabolism Service, Department of Internal Medicine, Hadassah-Hebrew University Medical Center, Jerusalem 91120, Israel *Correspondence: [email protected] Running title: The genetic program of pancreatic β-cell replication 1 Diabetes Publish Ahead of Print, published online March 18, 2016 Diabetes Page 2 of 65 Abstract The molecular program underlying infrequent replication of pancreatic beta- cells remains largely inaccessible. Using transgenic mice expressing GFP in cycling cells we sorted live, replicating beta-cells and determined their transcriptome. Replicating beta-cells upregulate hundreds of proliferation- related genes, along with many novel putative cell cycle components. Strikingly, genes involved in beta-cell functions, namely glucose sensing and insulin secretion were repressed. Further studies using single molecule RNA in situ hybridization revealed that in fact, replicating beta-cells double the amount of RNA for most genes, but this upregulation excludes genes involved in beta-cell function.
    [Show full text]
  • Xenopus in the Amphibian Ancestral Organization of the MHC Revealed
    Ancestral Organization of the MHC Revealed in the Amphibian Xenopus Yuko Ohta, Wilfried Goetz, M. Zulfiquer Hossain, Masaru Nonaka and Martin F. Flajnik This information is current as of September 26, 2021. J Immunol 2006; 176:3674-3685; ; doi: 10.4049/jimmunol.176.6.3674 http://www.jimmunol.org/content/176/6/3674 Downloaded from References This article cites 70 articles, 21 of which you can access for free at: http://www.jimmunol.org/content/176/6/3674.full#ref-list-1 Why The JI? Submit online. http://www.jimmunol.org/ • Rapid Reviews! 30 days* from submission to initial decision • No Triage! Every submission reviewed by practicing scientists • Fast Publication! 4 weeks from acceptance to publication *average by guest on September 26, 2021 Subscription Information about subscribing to The Journal of Immunology is online at: http://jimmunol.org/subscription Permissions Submit copyright permission requests at: http://www.aai.org/About/Publications/JI/copyright.html Email Alerts Receive free email-alerts when new articles cite this article. Sign up at: http://jimmunol.org/alerts The Journal of Immunology is published twice each month by The American Association of Immunologists, Inc., 1451 Rockville Pike, Suite 650, Rockville, MD 20852 Copyright © 2006 by The American Association of Immunologists All rights reserved. Print ISSN: 0022-1767 Online ISSN: 1550-6606. The Journal of Immunology Ancestral Organization of the MHC Revealed in the Amphibian Xenopus1 Yuko Ohta,2* Wilfried Goetz,* M. Zulfiquer Hossain,* Masaru Nonaka,† and Martin F. Flajnik* With the advent of the Xenopus tropicalis genome project, we analyzed scaffolds containing MHC genes. On eight scaffolds encompassing 3.65 Mbp, 122 MHC genes were found of which 110 genes were annotated.
    [Show full text]